Roche Holding AG on Wednesday posted a decline in sales for the first quarter as its diagnostics division suffered from significantly lower demand for Covid-19 tests, and backed its outlook for the year. The Swiss pharma major reported sales of 15.32 billion euros ($16.82 billion) for the first…
#rocheholdingag #chf03 #omicron
Continue reading...